March 23rd 2006Panel mutes� ADHD drug warnings
A federal advisory panel on Wednesday rejected recommending that popular drugs used to treat attention deficit hyperactivity disorder should bear the strongest type of warning of the potential cardiovascular and psychiatric risks they pose.

March 23rd 2006Strongest warnings on ADHD drugs rejected
Federal health advisers said Wednesday that Ritalin and other drugs for attention deficit hyperactivity disorder should not carry strong “black-box” warnings about potential cardiovascular and psychiatric risks.